Account
Articles
18.06.2024
What does it take to secure access to digital heal...

Article originally published 11th August 2022, updated 18th June 2024. Introduction Digital health a...

Read more
Articles
11.06.2024
AI could transform diabetes management to improve ...

Article originally published 17th August 2022, updated 11th June 2024. Introduction Artificial intel...

Read more
Articles
05.06.2024
The impact of AI on drug pricing and reimbursement

Artificial intelligence is set to revolutionise the market access and healthcare landscape, but huma...

Read more
Articles
29.05.2024
EU HTA regulation

Learn how to navigate the upcoming EU HTA regulation and optimise market access strategies for oncol...

Read more
Articles
21.05.2024
How are local markets adapting their HTA evaluatio...

Our experts analyse how local European markets are integrating the EU HTA outputs into national proc...

Read more
Articles
15.05.2024
Navigating the new EU HTA regulation: organisation...

Our latest article summarises the key changes to be aware of for the upcoming EU HTA, as well as imp...

Read more
Articles
02.04.2024
Does price vs volume rule apply for CAR-Ts conside...

We explore CAR T-cell therapy challenges, regulatory approvals, market growth, pricing models, and a...

Read more
Articles
27.03.2024
How will recent safety signals impact patient acce...

Safety signals have sparked vital discussions on patient access to ATMPs, marking a pivotal moment i...

Read more
Articles
05.03.2024
VPAG for manufacturers: boom or gloom for UK launc...

We discuss the 2024 VPAG agreement, how it differs from the previous VPAS and whether this will impa...

Read more
Articles
15.02.2024
PATT 2.0: NICE Priorities & Pharma Impact

We examine the effects on patient access, specifically regarding pathways, high value steps, multi-i...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.